from lessons learned

 

Ahern, J., Stuber, J., & Galea, S. (2007).
Stigma, discrimination and the health of illicit drug users. Drug and Alcohol Dependence, 88(2-3), 188–96. doi:10.1016/j.drugalcdep.2006.10.014

 

Corazza, O., Simonato, P., Corkery, J., Trincas, G., & Schifano, F.
“Legal highs”: safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Rivista Di Psichiatria, 49(2), 89–94. doi:10.1708/1461.16147

 

DeLoache, W. C., Russ, Z. N., Narcross, L., Gonzales, A. M., Martin, V. J. J., & Dueber, J. E. (2015).
An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nature Chemical Biology. doi:10.1038/nchembio.1816

 

EMCDDA. (2015).
New psychoactive substances in Europe : An update from the EU Early Warning System. Luxembourg. Doi:10.2810/372415

 

Erickson, P.G., Adlaf, E.M., Smart, R.G. and Murray, G. F. (1994).
The Steel Drug. Cocaine and Crack in Perspective, Lexington Books, New York, NY. - Cerca con Google. (N. Lexington Books, New York, Ed.).

 

Ferrence, R. (2001).
Diffusion theory and drug use. Addiction (Abingdon, England), 96(1), 165–73. doi:10.1080/09652140020017030

 

Fossati, E., Narcross, L., Ekins, A., Falgueyret, J.-P., & Martin, V. J. J. (2015).
Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae. PloS One, 10(4), e0124459. doi:10.1371/journal.pone.0124459

 

Fountoulakis, K. N., & Theodorakis, P. N. (2014).
Austerity and health in Greece. Lancet, 383(9928), 1543. doi:10.1016/S0140-6736(14)60739-X

 

Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M., & Smolke, C. D. (2015).
Complete biosynthesis of opioids in yeast. Science, 349(6252), 1095–1100. doi:10.1126/science.aac9373

 

Giné, C. V., Espinosa, I. F., & Vilamala, M. V.
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Testing and Analysis, 6(7-8), 819–24. doi:10.1002/dta.1610

 

Grund, J., Coffin, P., Jauffret-roustide, M., Dijkstra, M., Bruin, D. De, & Bruin, D. de. (2010).
The fast and furious — cocaine , amphetamines and harm reduction. Harm Reduction: Evidence, Impacts and Challenges, 191–232. Retrieved from
http://www.mendeley.com/research/fast-furious-cocaine-amphetamines-harm-reduction/?utm_source=desktop&utm_medium=1.12.4&utm
_campaign=open_catalog&userDocumentId={c5051c4e-fddd-4047-9aac-d97d45aa8041}

 

Grund, J. P., Adriaans, N. F., & Kaplan, C. D. (1991).
Changing cocaine smoking rituals in the Dutch heroin addict population. British Journal of Addiction, 86(4), 439–448.

 

Grund, J. P., Blanken, P., Kaplan, C. D., Verveen, J., Hartgers, C., Van Den Hoek, J. A., & Leenders, F. (1992).
The relationship between Dutch drug policy and injecting drug use: current injecting and heroin use onset date. IntConfAIDS, 8, D400.

 

Grund, J.-P. C., & Blanken, P. (1993).
From “Chasing the Dragon” to “Chinezen”: the Diffusion of Heroin Smoking in the Netherlands. Addiction Research Institute (IVO), Rotterdam. Retrieved from
http://www.drugtext.org/pdf/grund02.pdf

 

Grund, J.-P. C., Vavrincikova, L., Janikova, B., Fidesova, H., & Miovsky, M. (2016).
The Emperor’s New Clothes? Highlights from the NPSinEurope.eu Rapid Assessment & Response Study of New Psychoactive Drugs in five EU Member States. Adiktologie.

 

Grund J-PC. (2015).
Technology & Drugs. The End of Drug Policy as We Know It? Presented in parallel Session 54, “Internet, Unternet & Harm Reduction,” International Harm Reduction Conference, Kuala Lumpur, 21-10-2015.

 

Hedrich, D., Kalamara, E., Sfetcu, O., Pharris, A., Noor, A., Wiessing, L., … de laar, M. Van. (2013).
Human immunodeficiency virus among people who inject drugs: Is risk increasing in Europe? EUROSURVEILLANCE, 18(48), 7–12. Retrieved from
http://apps.webofknowledge.com.proxy.library.uu.nl/full_record.do?product=WOS&search_mode=GeneralSearch&qid=1&SID=P152BEcZ9jxdejPwF7j&page=1&doc=2

 

Janikova, B., Fidesova, H., Vavrincikova, L., Miovsky, M., & Grund, J.-P. C. (2016).
New Psychoactive Substances among People Who Use Drugs Heavily in Europe: Novel Drugs, Vintage Problems & Responses. Adiktologie.

 

Katz, E., Levin, M. L., & Hamilton, H. (1963).
Traditions of Research on the Diffusion of Innovation. American Sociological Review, 28(2), 237–252. doi:10.2307/2090611

 

Kentikelenis, A., Karanikolos, M., Reeves, A., McKee, M., & Stuckler, D. (2014).
Greece’s health crisis: from austerity to denialism. Lancet, 383(9918), 748–53. doi:10.1016/S0140-6736(13)62291-6

 

Kwasniewski, A. (2012). Saying No to Costly Drug Laws. The New York Times, Opinion Pages, May 10, 2012.
http://www.nytimes.com/2012/05/11/opinion/saying-no-to-costly-drug-laws.html?_r=0

 

Merton, R. K. (1936).
The Unanticipated Consequences of Purposive Social Action. American Sociological Review, 1(6), 894-904.

 

Myers, R. (2008).
Responding to the Time-Based Failures of the Criminal Law Through a Criminal Sunset Amendment. Retrieved from
http://papers.ssrn.com/abstract=2166410

 

Parker, H., Newcombe, R., & Bakx, K. (1987).
The New Heroin Users: prevalence and characteristics in Wirral, Merseyside. Addiction, 82(2), 147–157. doi:10.1111/j.1360-0443.1987.tb01453.x

 

Péterfi, A., Tarján, A., Horváth, G. C., Csesztregi, T., & Nyírády, A. (2014).
Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones. Drug Testing and Analysis, 6(7-8), 825–31. doi:10.1002/dta.1625

 

Power, M. (2013).
Drugs 2.0: The Web Revolution That’s Changing How the World Gets High. Portobello Books Ltd. Retrieved October 22, 2014, from
http://www.amazon.com/Drugs-2-0-Revolution-Thats-Changing/dp/1846274591

 

Rogers, E. M. (2003).
Diffusion of Innovations 5th ed. New York NY Free Press. Free Press. Retrieved from
http://books.google.com/books?id=9U1K5LjUOwEC&pgis=1

 

Tarján, A., Dudás, M., Gyarmathy, V. A., Rusvai, E., Tresó, B., & Csohán, Á. (2015).
Emerging Risks Due to New Injecting Patterns in Hungary During Austerity Times. Substance Use & Misuse, 1–11. doi:10.3109/10826084.2015.978672

 

TNS Political & Social. (2014)
Flash Eurobarometer 401 Young People And Drugs Report.
http://ec.europa.eu/public_opinion/flash/fl_401_en.pdf

 

Travis, A. (2016).
Ban on legal highs delayed over concerns law is not enforceable. The Guardian.
http://www.theguardian.com/society/2016/mar/30/legal-highs-ban-uk-delayed-concerns-law-enforceable-psychoactive-definition

 

UNODC. (2013).
The Challenge of New Psychoactive Substances. Vienna. Retrieved from
http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf

 

Westermeyer, J. (1976).
The pro-heroin effects of anti-opium laws in Asia. Archives of General Psychiatry, 33(9), 1135–9. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/962496

 

Zamengo, L., Frison, G., Bettin, C., & Sciarrone, R. (2014).
Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicology Letters, 229(1), 220–8. doi:10.1016/j.toxlet.2014.06.012

 

Zirpel, B., Stehle, F., & Kayser, O. (2015).
Production of 9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing 9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. Biotechnology Letters, 37(9), 1869–75. doi:10.1007/s10529-015-1853-x

 

 

 

 

Defining NPS

New to Whom?

UNODC defines new psychoactive substancesor NPS as:... read more

 

Defining Target Groups

Defining the Project’s target audience or end beneficiaries comes with considerable difficulties. The official project title... read more

 

 

publications

 

Project News

nps mini

Addictology, the Czech based journal for research into addiction, published a special issue on NPS related articles, including those with the outcomes of the NPS in Europe project.
read more...

nps mini

The NPS staff presented project outcomes at the International Harm Reduction Conference in Kuala Lumpur, Malaysia.
read more...


nps mini
SEMINAR
NPS Policy: Moving Forward
Leading European experts, including researchers, practitioners and policy makers will meet at a Seminar in Lisbon on the 26th of November to discuss the latest developments in the field of New Psychoactive Substances (NPS).
read more...

nps mini
The NPS in Europe project organises a training on new psychoactive substances (nps), 23 - 25 November 2015 in Lisbon, Portugal. The training is aimed at service provider and peers, supporting NPS users in Europe. The course will give an overview of relevant NPS substances, identify current patterns and develop effective harm reduction service responses.
read more..

Practical information...


nps mini
NPS in Europe

is launching a questionnaire on NPS use in all European countries.